Advertisement
  • “Congrats! You Have the ‘Good’ Cancer”

    Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer.

    by Carly Flumer

  • POLICY MATTERS

    Keep Up Momentum for Medical Research Funding

    Advocating for federal funds for medical research pays off when the effort is constant and compelling.

    by Brandon L. Leonard, MA, and J. Tod Guidry, PhD

  • Get Involved

    Creative Therapy

    Various kinds of artistic expression can play a role in processing the emotional effects of cancer.

    by Bradley Jones

  • Secure Connections

    Patients find each other online and get support they say is unparalleled, but with openness comes concern about privacy.

    by Kate Yandell

  • Survivor Profile

    Handle With Care

    Brain cancer survivor Lanette Veres sends cards and packages to others with the disease. She believes no one should face cancer alone.

    by Lindsey Konkel

  • FORWARD LOOK

    Targeted Treatments for Tots

    New law mandates that cancer drugs get tested in kids in clinical trials.

    by Sharon Tregaskis

  • FORWARD LOOK

    Medicare to Cover CAR-T Cell Therapy

    High cost may still limit access.

    by Nancy Averett

  • Cancer Patient Advocates Find Strength in Numbers

    Patient advocates have become a vital part of the San Antonio Breast Cancer Symposium. Opportunities for advocates continue to multiply.

    by Marci A. Landsmann

  • Cancer and Credit

    The financial burden of a cancer diagnosis can lower a patient’s credit score.

    by Shelly Rosenfeld

  • First Ladies of Africa Issue Call to Address Cancer Crisis

    A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.

    by Bradley D. Miller, PhD

Advertisement

From the AACR

  • Experts' Forecast: 2020

    As a new decade begins to unfold, what advancements can we expect in the field of oncology?

  • New FDA Approval

    The U.S. Food and Drug Administration expanded the use of a targeted therapeutic to include treating certain patients with pancreatic cancer.

  • 2019 in Review

    Research continued to drive progress across the spectrum of cancer care in the form of new ways to prevent, detect, diagnose, and treat the disease.

Advertisement

Video

Follow My Lead

Advertisement

social media

donate to the AACR